Evidence map›Paper›PMID 20304107›Full record

ArticleBiochimica et biophysica acta2010

Restricted domain mobility in the Candida albicans Ess1 prolyl isomerase.

Lynn McNaughton, Zhong Li, Patrick Van Roey, Steven D Hanes, David M LeMaster

Abstract read
In one paragraph

Article in Biochimica et biophysica acta, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lynn McNaughtonWadsworth Center, New York State Department of Health, School of Public Health, University at Albany, Empire State Plaza, Albany, NY 12201, USA.
Zhong Li
Patrick Van Roey
Steven D Hanes
David M LeMaster

Funding

Yeast Ess1, a Conserved PPlase Essential for MitosisR01GM055108 · NIGMS · WADSWORTH CENTER · PI HANES, STEVEN D. · 1997 to 2010
$2.5M
NIGMS NIH HHS GM055108NIGMS NIH HHS R01 GM055108
6 · The paper itself

Abstract

Ess1 is a peptidyl prolyl cis/trans isomerase that is required for virulence of the pathogenic fungi Candida albicans and Cryptococcus neoformans. The enzyme isomerizes the phospho-Ser-Pro linkages in the C-terminal domain of RNA polymerase II. Its human homolog, Pin1, has been implicated in a wide range of human diseases, including cancer and Alzheimer's disease. Crystallographic and NMR studies have demonstrated that the sequence linking the catalytic isomerase domain and the substrate binding WW domain of Pin1 is unstructured and that the two domains are only loosely associated in the absence of the substrate. In contrast, the crystal structure of C. albicans Ess1 revealed a highly ordered linker that contains a three turn alpha-helix and extensive association between the two tightly juxtaposed domains. In part to address the concern that the marked differences in the domain interactions for the human and fungal structures might reflect crystal lattice effects, NMR chemical shift analysis and 15N relaxation measurements have been employed to confirm that the linker of the fungal protein is highly ordered in solution. With the exception of two loops within the active site of the isomerase domain, the local backbone geometry observed in the crystal structure appears to be well preserved throughout the protein chain. The marked differences in interdomain interactions and linker flexibility between the human and fungal enzymes provide a structural basis for therapeutic targeting of the fungal enzymes.

Indexed as

Candida albicansCatalytic DomainCrystallography, X-RayFungal ProteinsHumansMagnetic Resonance SpectroscopyModels, MolecularMolecular ConformationNIMA-Interacting Peptidylprolyl IsomerasePeptidylprolyl IsomeraseProtein ConformationProtein Structure, TertiaryRecombinant ProteinsTime FactorsFungal ProteinsNIMA-Interacting Peptidylprolyl IsomerasePeptidylprolyl IsomerasePIN1 protein, humanRecombinant Proteins

Identifiers

PMID20304107
PMCPMC2951753

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.